National surveillance using a clinical quality indicator for prolonged antipsychotic use among older Australians with dementia who access aged care services

被引:2
作者
Sluggett, Janet K. [1 ,2 ]
Caughey, Gillian E. [1 ,2 ]
Air, Tracy [2 ]
Cations, Monica [2 ,3 ]
Lang, Catherine E. [2 ]
Ward, Stephanie A. [4 ,5 ,6 ]
Ahern, Susannah [6 ]
Lin, Xiaoping [6 ]
Wallis, Kasey [6 ]
Crotty, Maria [7 ,8 ]
Inacio, Maria C. [1 ,2 ]
机构
[1] Univ South Australia, UniSA Allied Hlth & Human Performance, GPO Box 2471, Adelaide, SA, Australia
[2] South Australian Hlth & Med Res Inst, Registry Sr Australians ROSA, Adelaide, SA, Australia
[3] Flinders Univ S Australia, Coll Educ Psychol & Social Work, Adelaide, SA, Australia
[4] Univ New South Wales, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia
[5] Prince Wales Hosp, Dept Geriatr Med, Randwick, NSW 2031, Australia
[6] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[7] Southern Adelaide Local Hlth Network, SA Hlth, Adelaide, SA, Australia
[8] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
antipsychotic agents; Australia; dementia; drug utilization; health care; home care services; long-term care; medication adherence; nursing homes; quality indicators; ALZHEIMERS-DISEASE; PREVALENCE; FRACTURE; RISK;
D O I
10.1002/gps.6089
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Dementia guidelines recommend antipsychotics are only used for behavioral and psychological symptoms when non-drug interventions fail, and to regularly review use. Population-level clinical quality indicators (CQIs) for dementia care in permanent residential aged care (PRAC) typically monitor prevalence of antipsychotic use but not prolonged use. This study aimed to develop a CQI for antipsychotic use >90 days and examine trends, associated factors, and variation in CQI incidence; and examine duration of the first episode of use among individuals with dementia accessing home care packages (HCPs) or PRAC. Methods: Retrospective cohort study, including older individuals with dementia who accessed HCPs (n = 50,257) or PRAC (n = 250,196). Trends in annual CQI incidence (2011-12 to 2015-16) and associated factors were determined using Poisson regression. Funnel plots examined geographical and facility variation. Time to antipsychotic discontinuation was estimated among new antipsychotic users accessing HCP (n = 2367) and PRAC (n = 15,597) using the cumulative incidence function. Results: Between 2011-12 and 2015-16, antipsychotic use for >90 days decreased in HCP recipients from 10.7% (95% CI 10.2-11.1) to 10.1% (95% CI 9.6-10.5, adjusted incidence rate ratio (aIRR) 0.97 (95% CI 0.95-0.98)), and in PRAC residents from 24.5% (95% CI 24.2-24.7) to 21.8% (95% CI 21.5-22.0, aIRR 0.97 (95% CI 0.96-0.98)). Prior antipsychotic use (both cohorts) and being male and greater socioeconomic disadvantage (PRAC cohort) were associated with higher CQI incidence. Little geographical/facility variation was observed. Median treatment duration in HCP and PRAC was 334 (interquartile range [IQR] 108-958) and 555 (IQR 197-1239) days, respectively. Conclusions: While small decreases in antipsychotic use >90 days were observed between 2011-12 and 2015-16, findings suggest antipsychotic use among aged care recipients with dementia can be further minimized.
引用
收藏
页数:11
相关论文
共 62 条
  • [1] [Anonymous], 2016, Main Structure and Greater Capital City Statistical Areas
  • [2] [Anonymous], 2016, The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia [electronic resource]
  • [3] Australian Bureau of Statistics, 2018, 2033055001 CENSUS PO
  • [4] Australian Commission on Safety and Quality in Health Care, 2020, Medication without harm-WHO Global Patient Safety Challenge. Australia's response
  • [5] Australian Government, 2022, My Aged Care
  • [6] Australian Government Department of Health, 2021, AUSTR GOVT RESPONSE
  • [7] Australian Government Department of Health, 2021, National Aged Care Mandatory Quality Indicator Program (QI Program) Manual 2.0-Part B Internet
  • [8] Australian Government Department of Health and Aged Care, 2023, Pharmaceutical Benefits Scheme (PBS) expenditure and prescriptions report 1 July 2022 to 30 June 2023
  • [9] Australian Institute of Health and Welfare (AIHW), 2022, GEN Aged Care Data. People's care needs in aged care
  • [10] How Can Quality of Dementia Care Be Measured? The Development of Clinical Quality Indicators for an Australian Pilot Dementia Registry
    Ayton, Darshini
    Gardam, Madeleine
    Ward, Stephanie
    Brodaty, Henry
    Pritchard, Elizabeth
    Earnest, Arul
    Krysinska, Karolina
    Banaszak-Holl, Jane
    McNeil, John
    Ahern, Susannah
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (03) : 923 - 936